Showing results (171-180 of 315) with videos related to

Sort By:
Pageof 32
Diabetes, Obesity & Metabolism|December 27, 2023
Elucidating the glucose-lowering effect of the bile acid sequestrant sevelamerHenriette H Nerild, Andreas Brønden, Abdullah E Haddouchi, et al.
Journal of Lipid Research|October 3, 2025
Selective agonism of liver and gut FXR prevents cholestasis and intestinal atrophy in parenterally fed neonatal pigsYanjun Jiang, Zhengfeng Fang, Gregory Guthrie, et al.
Langenbeck'S Archives of Surgery|October 20, 2018
Quantitative perfusion assessment of intestinal anastomoses in pigs treated with glucagon-like peptide 2Nikolaj Nerup, Linea Landgrebe Ring, Rune Broni Strandby, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Selective Agonism of Liver and Gut FXR Prevents Cholestasis and Intestinal Atrophy in Parenterally Fed Neonatal PigsYanjun Jiang, Zhengfeng Fang, Gregory Guthrie, et al.
Bone|February 8, 2023
Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetesNiels B Dalsgaard, Lærke S Gasbjerg, Mads M Helsted, et al.
Physiological Reports|September 19, 2022
Prolonged lipopolysaccharide-induced illness elevates glucagon-like peptide-1 and suppresses peptide YY: A human-randomized cross-over trialKatrine Brodersen, Maike Mose, Ulla Ramer Mikkelsen, et al.
Diabetologia|August 18, 2021
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trialSebastian M N Heimbürger, Bjørn Hoe, Chris N Nielsen, et al.
Diabetes|July 3, 2025
β-Cell Function and Sensitivity to Incretins Before and After Roux-en-Y Gastric Bypass in Individuals With Type 2 DiabetesMaria S Svane, Morten Hindsø, Christoffer Martinussen, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 19, 2026
Impact of intestinal resections on the secretion of gastrointestinal hormonesIsmail Pinar, Julie Hvid Møller Andersen, Sofie Lund, et al.
Diabetes, Obesity & Metabolism|June 7, 2022
Hypoglycaemia and rebound hyperglycaemia increase left ventricular systolic function in patients with type 1 diabetesChristine R Andreasen, Andreas Andersen, Per G Hagelqvist, et al.
Pageof 32